Revenue YoY
+11.22%
Operating Income YoY
+11.38%
Net Income YoY
+16.20%
Net Margin Δ
+77 bps
Net income bridge for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $75.5M+16.20%
Profit bridge breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $467M | — |
| Revenue | $325M | +430.2% |
| Cost of Revenue | -$161M | -213.8% |
| Operating Expenses | -$95.4M | -126.4% |
| Other Income / Expense | $31.1M | +41.2% |
| Income Tax | -$27M | -35.8% |
| Other Items | $3.4M | +4.5% |
| Net Income | $543M | — |
- Prior Net Income$467M
- Revenue$325M
- Cost of Revenue-$161M
- Operating Expenses-$95.4M
- Other Income / Expense$31.1M
- Income Tax-$27M
- Other Items$3.4M
- Net Income$543M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.65% TTM
- Dividend Profile0.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.